Literature DB >> 7577028

Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer.

Y Moriya1, K Sugihara, T Akasu, S Fujita.   

Abstract

133 patients who underwent nerve-sparing surgery with lateral dissection for lower rectal cancer were analysed for survival and functional results, operative burdens, and modes of recurrence. In 84% of patients an acceptable urinary function was preserved. Operative time averaged 334 min, and blood loss averaged 935 ml. The 5-year survival rate was 67% in all patients, and 88% for Dukes' A, 74% for Dukes' B and 59% for Dukes' C. According to the number of positive nodes, the 5-year survival rate comprised 83% of patients with up to three nodes, and 34% of those with more than four nodes. Local recurrent rates were 2.7% in patients with Dukes' B and 13% with Dukes' C. At present, pelvic nerve-sparing procedures with lateral dissection is the most promising surgery, guaranteeing both adequate lymphadenectomy and preservation of urinary function.

Entities:  

Mesh:

Year:  1995        PMID: 7577028     DOI: 10.1016/0959-8049(95)00164-e

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  34 in total

Review 1.  The quest for precision in transanal total mesorectal excision.

Authors:  A G Franchini Melani; M Diana; J Marescaux
Journal:  Tech Coloproctol       Date:  2015-11-26       Impact factor: 3.781

2.  Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.

Authors:  Atsushi Ogura; Tsuyoshi Konishi; Chris Cunningham; Julio Garcia-Aguilar; Henrik Iversen; Shigeo Toda; In Kyu Lee; Hong Xiang Lee; Keisuke Uehara; Peter Lee; Hein Putter; Cornelis J H van de Velde; Geerard L Beets; Harm J T Rutten; Miranda Kusters
Journal:  J Clin Oncol       Date:  2018-11-07       Impact factor: 44.544

3.  Alla ricerca dei chirurghi perduti CHARLES PIERRE DENONVILLIERS E LA "SUA" APONEUROSI.

Authors:  G Di Matteo
Journal:  G Chir       Date:  2017 Mar-Apr

4.  Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer.

Authors:  Kennoki Kyo; Shinichi Sameshima; Minoru Takahashi; Taiki Furugori; Toshio Sawada
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

5.  Improving prediction of lateral node spread in low rectal cancers--multivariate analysis of clinicopathological factors in 1,046 cases.

Authors:  Kok-Yang Tan; Seiichiro Yamamoto; Shin Fujita; Takayuki Akasu; Yoshihiro Moriya
Journal:  Langenbecks Arch Surg       Date:  2010-04-02       Impact factor: 3.445

6.  Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection.

Authors:  Hideki Ueno; Hidetaka Mochizuki; Yojiro Hashiguchi; Megumi Ishiguro; Masayoshi Miyoshi; Yoshiki Kajiwara; Taichi Sato; Hideyuki Shimazaki; Kazuo Hase
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

Review 7.  Is There Any Reason to Still Consider Lateral Lymph Node Dissection in Rectal Cancer? Rationale and Technique.

Authors:  Miranda Kusters; Keisuke Uehara; Cornelis J H van de Velde; Yoshihiro Moriya
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

Review 8.  Function preservation in rectal cancer surgery.

Authors:  Yoshihiro Moriya
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

Review 9.  The role of lateral lymph node dissection in the management of lower rectal cancer.

Authors:  Ziting Wang; Kep Yong Loh; Kok-Yang Tan; Emile Chung-Hou Woo
Journal:  Langenbecks Arch Surg       Date:  2011-11-22       Impact factor: 3.445

10.  Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancer.

Authors:  Shin Fujita; Seiichiro Yamamoto; Takayuki Akasu; Yoshihiro Moriya
Journal:  Int J Colorectal Dis       Date:  2009-04-23       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.